In what has become routine for Johnson & Johnson (J&J), the company issued a late-Friday recall for numerous lots of its Velcade oncology treatment. The product is co-marketed with Millennium Pharmaceuticals (U.S.) and J&J taking rest-of-world responsibilities.
The culprit for J&J this time is white particles floating in the medicine. The particles were identified as a “polyester-like material.” It makes one wonder about the integrity of the manufacturing processes over at J&J/Millennium.
It is important to note that J&J actually issued a recall for the product, vs. secretly getting the products off the market. J&J is not expecting to receive many doses back, since most of them have already been injected into unsuspecting patients. J&J spokeswoman Kellie McLaughlin was quick to add that the company is not aware of any patient injuries due to the contaminated Velcade.
The culprit for J&J this time is white particles floating in the medicine. The particles were identified as a “polyester-like material.” It makes one wonder about the integrity of the manufacturing processes over at J&J/Millennium.
It is important to note that J&J actually issued a recall for the product, vs. secretly getting the products off the market. J&J is not expecting to receive many doses back, since most of them have already been injected into unsuspecting patients. J&J spokeswoman Kellie McLaughlin was quick to add that the company is not aware of any patient injuries due to the contaminated Velcade.